H.R. 11045: Preventing Overdoses with Test Strips Act
This bill would let certain federal grant programs pay for devices used to check drugs for dangerous additives before use. In plain terms, it would make it easier for grant recipients to use federal money to buy or use fentanyl test strips, xylazine test strips, and similar drug-checking tools.
What changes it makes
- It amends the 21st Century Cures Act so that grant programs aimed at addressing substance use and overdose prevention can cover expenses for “adulterant substance detection devices.”
- It also amends the Public Health Service Act so that the Substance Abuse and Mental Health Services Administration (SAMHSA) can treat these devices as allowable expenses in its grants, contracts, and cooperative agreements.
What counts as a covered device
The bill defines an “adulterant substance detection device” as a device, including a test strip, that can detect the presence of an adulterant such as fentanyl, xylazine, or another added substance in a drug sample before the drug is used.
Practical effect
The bill would not require anyone to use these devices. Instead, it would make sure that organizations receiving certain federal substance-use-related funding are allowed to spend that money on drug-checking tools if they choose to do so.
Relevant Companies
- None found
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
3 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Nov. 17, 2026 | Introduced in House |
| Nov. 17, 2026 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.